OpenFilings
Cidara Therapeutics, Inc.
Form
8-K
Report Period
2025-01-03
Date Filed
2025-01-07
Time Filed
17:12:13
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CIDARA THERAPEUTICS, INC. FORM 8-K
SEPARATION AGREEMENT
AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Filing on SEC Edgar